Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
组蛋白去乙酰化酶抑制剂罗米地辛单药治疗皮肤T细胞淋巴瘤患者的II期多中心试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2008.21.6150
Piekarz, Richard L; Frye, Robin; Turner, Maria; Wright, John J; Allen, Steven L; Kirschbaum, Mark H; Zain, Jasmine; Prince, H Miles; Leonard, John P; Geskin, Larisa J; Reeder, Craig; Joske, David; Figg, William D; Gardner, Erin R; Steinberg, Seth M; Jaffe, Elaine S; Stetler-Stevenson, Maryalice; Lade, Stephen; Fojo, A Tito; Bates, Susan E
表观遗传
T细胞
淋巴瘤
T细胞
乙酰化
细胞生物学
免疫/内分泌